Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R A Morgan

Showing results (21-30 of 173) with videos related to

Pageof 18
Sort By:
Human Gene Therapy|October 6, 2000
Potent inhibition of human immunodeficiency virus type 1 replication by conditionally replicating human immunodeficiency virus-based lentiviral vectors expressing envelope antisense mRNAM R Mautino, R A Morgan
Gene Therapy|April 9, 2002
Inhibition of HIV-1 replication by novel lentiviral vectors expressing transdominant Rev and HIV-1 env antisenseM R Mautino, R A Morgan
Seminars in Vascular Surgery|December 20, 2016
Percutaneous interventions following endovascular aneurysm sac sealing: Endoleak embolization and limb-related adverse eventsS Ameli-Renani, R A Morgan
Developmental Genetics|January 1, 1987
Post-transcriptional regulation and DNA undermethylation of intracisternal A particle genes in embryonal carcinoma cell linesR A Morgan, R C Huang
Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie|January 1, 1974
What can we do for dyslexics?R A Morgan, E A Fernandes
Clinical Microbiology Reviews|February 11, 1998
Gene therapy for infectious diseasesB A Bunnell, R A Morgan
Biotechnology Letters|October 10, 2006
IgE binding to proteins from sesame and assessment of allergenicity: implications for biotechnology?Estibalitz Orruño, Michael R A Morgan
Human Gene Therapy|May 26, 1999
Production of minigene-containing retroviral vectors using an alphavirus/retrovirus hybrid vector systemJ J Wahlfors, R A Morgan
Techniques in Vascular and Interventional Radiology|December 19, 2001
Malignant biliary disease: percutaneous interventionsR A Morgan, A N Adam
Canadian Medical Association Journal|February 15, 1984
Buying and using an office computerR A Morgan, D K Morgan
Pageof 18

Showing results (21-30 of 173) with videos related to

Sort By:
Pageof 18
Human Gene Therapy|October 6, 2000
Potent inhibition of human immunodeficiency virus type 1 replication by conditionally replicating human immunodeficiency virus-based lentiviral vectors expressing envelope antisense mRNAM R Mautino, R A Morgan
Gene Therapy|April 9, 2002
Inhibition of HIV-1 replication by novel lentiviral vectors expressing transdominant Rev and HIV-1 env antisenseM R Mautino, R A Morgan
Seminars in Vascular Surgery|December 20, 2016
Percutaneous interventions following endovascular aneurysm sac sealing: Endoleak embolization and limb-related adverse eventsS Ameli-Renani, R A Morgan
Developmental Genetics|January 1, 1987
Post-transcriptional regulation and DNA undermethylation of intracisternal A particle genes in embryonal carcinoma cell linesR A Morgan, R C Huang
Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie|January 1, 1974
What can we do for dyslexics?R A Morgan, E A Fernandes
Clinical Microbiology Reviews|February 11, 1998
Gene therapy for infectious diseasesB A Bunnell, R A Morgan
Biotechnology Letters|October 10, 2006
IgE binding to proteins from sesame and assessment of allergenicity: implications for biotechnology?Estibalitz Orruño, Michael R A Morgan
Human Gene Therapy|May 26, 1999
Production of minigene-containing retroviral vectors using an alphavirus/retrovirus hybrid vector systemJ J Wahlfors, R A Morgan
Techniques in Vascular and Interventional Radiology|December 19, 2001
Malignant biliary disease: percutaneous interventionsR A Morgan, A N Adam
Canadian Medical Association Journal|February 15, 1984
Buying and using an office computerR A Morgan, D K Morgan
Pageof 18